Leading people in the age of Al

As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair

- Lakshmipriya Nair

AI is no longer changing just one part of pharma. It is reshaping everything, all at once. R&D teams are identifying drug candidates in weeks instead of years. Manufacturing floors are catching quality issues before they happen. Regulatory submissions are being drafted in minutes, not days. Field teams are being evaluated and optimised by algorithms. According to a report titled, 'Scaling gen AI in the life sciences industry', researchers from McKinsey Global Institute, estimated that generative AI alone could unlock $60-110 billion annually for the pharma and medical-products sector by accelerating discovery, speeding development and improving commercialisation.

Individually, these changes look like upgrades. Together, they signal something much bigger. A fundamental shift in how pharma organisations think, decide and operate.

And right at the centre of this shift is a function being redefined in real time: HR.

A transforming playbook

The questions HR leaders are being asked today look very different from before. It used to be about headcount, appraisals, attrition and hiring metrics. Now it is this: How do we lead people through a technological revolution that is rewriting the rules of one of the world's most regulated industries?

For the people inside pharma organisations, the nature of their work is changing, the skills required to do it well are changing, and the judgment they are expected to exercise is changing too.

This is not a talent question. It is not just about change management. It is a question about power, architecture and ownership. About who shapes the system before the system shapes the organisation.